vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and Bilibili Inc. (BILI). Click either name above to swap in a different company.
Bilibili Inc. is the larger business by last-quarter revenue ($1.3B vs $829.0M, roughly 1.5× Acadia Healthcare Company, Inc.). Bilibili Inc. runs the higher net margin — 6.0% vs 0.5%, a 5.4% gap on every dollar of revenue. On growth, Bilibili Inc. posted the faster year-over-year revenue change (26.2% vs 7.5%). Over the past eight quarters, Bilibili Inc.'s revenue compounded faster (27.3% CAGR vs 2.0%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
Bilibili, nicknamed B Site, is a Chinese online video sharing website based in Shanghai where users can submit, view, and add overlaid commentary on videos.
ACHC vs BILI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $1.3B |
| Net Profit | $4.5M | $75.7M |
| Gross Margin | — | 37.0% |
| Operating Margin | — | 5.8% |
| Net Margin | 0.5% | 6.0% |
| Revenue YoY | 7.5% | 26.2% |
| Net Profit YoY | -50.8% | 143.0% |
| EPS (diluted) | $0.05 | $1.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $1.3B | ||
| Q3 25 | $851.6M | $1.1B | ||
| Q2 25 | $869.2M | $1.0B | ||
| Q1 25 | $770.5M | $965.1M | ||
| Q4 24 | $774.2M | $1.0B | ||
| Q3 24 | $815.6M | $1.0B | ||
| Q2 24 | $796.0M | $843.1M |
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $75.7M | ||
| Q3 25 | $36.2M | $65.9M | ||
| Q2 25 | $30.1M | $30.5M | ||
| Q1 25 | $8.4M | $-1.5M | ||
| Q4 24 | $32.6M | $-176.0M | ||
| Q3 24 | $68.1M | $11.4M | ||
| Q2 24 | $78.5M | $83.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | 37.0% | ||
| Q3 25 | — | 36.7% | ||
| Q2 25 | — | 36.5% | ||
| Q1 25 | — | 36.3% | ||
| Q4 24 | — | 36.2% | ||
| Q3 24 | — | 34.9% | ||
| Q2 24 | — | 29.9% |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 5.8% | ||
| Q3 25 | 4.7% | 4.6% | ||
| Q2 25 | 5.8% | 3.4% | ||
| Q1 25 | 1.7% | 0.2% | ||
| Q4 24 | 4.9% | -16.0% | ||
| Q3 24 | 12.1% | 0.9% | ||
| Q2 24 | 13.4% | 9.5% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 6.0% | ||
| Q3 25 | 4.3% | 6.1% | ||
| Q2 25 | 3.5% | 3.0% | ||
| Q1 25 | 1.1% | -0.2% | ||
| Q4 24 | 4.2% | -17.5% | ||
| Q3 24 | 8.4% | 1.1% | ||
| Q2 24 | 9.9% | 9.9% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $1.14 | ||
| Q3 25 | $0.40 | $1.05 | ||
| Q2 25 | $0.33 | $0.51 | ||
| Q1 25 | $0.09 | $0.00 | ||
| Q4 24 | $0.36 | $0.21 | ||
| Q3 24 | $0.74 | $-0.03 | ||
| Q2 24 | $0.85 | $-0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $2.7B |
| Total DebtLower is stronger | $2.5B | $1.4B |
| Stockholders' EquityBook value | $2.0B | $2.2B |
| Total Assets | $5.5B | $5.9B |
| Debt / EquityLower = less leverage | 1.29× | 0.62× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $2.7B | ||
| Q3 25 | $118.7M | $2.4B | ||
| Q2 25 | $131.4M | — | ||
| Q1 25 | $91.2M | $1.9B | ||
| Q4 24 | $76.3M | $1.8B | ||
| Q3 24 | $82.1M | $11.7B | ||
| Q2 24 | $77.2M | — |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $1.4B | ||
| Q3 25 | $2.3B | $1.4B | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | $700.3M | ||
| Q4 24 | $2.0B | $662.5M | ||
| Q3 24 | $1.9B | $4.3B | ||
| Q2 24 | $1.8B | — |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $2.2B | ||
| Q3 25 | $3.1B | $2.1B | ||
| Q2 25 | $3.1B | — | ||
| Q1 25 | $3.0B | $2.0B | ||
| Q4 24 | $3.1B | $1.9B | ||
| Q3 24 | $3.0B | $13.7B | ||
| Q2 24 | $3.0B | — |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $5.9B | ||
| Q3 25 | $6.4B | $5.6B | ||
| Q2 25 | $6.3B | — | ||
| Q1 25 | $6.1B | $4.6B | ||
| Q4 24 | $6.0B | $4.5B | ||
| Q3 24 | $5.9B | $32.0B | ||
| Q2 24 | $5.7B | — |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 0.62× | ||
| Q3 25 | 0.74× | 0.65× | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | 0.35× | ||
| Q4 24 | 0.64× | 0.34× | ||
| Q3 24 | 0.62× | 0.31× | ||
| Q2 24 | 0.62× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | $263.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 13.78× | 3.47× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $263.1M | ||
| Q3 25 | $73.2M | $283.2M | ||
| Q2 25 | $133.5M | $277.7M | ||
| Q1 25 | $11.5M | $179.4M | ||
| Q4 24 | $116.7M | $191.9M | ||
| Q3 24 | $163.1M | $2.2B | ||
| Q2 24 | $171.1M | — |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | — | ||
| Q3 25 | $-63.0M | — | ||
| Q2 25 | $-34.2M | — | ||
| Q1 25 | $-163.2M | $174.5M | ||
| Q4 24 | $-86.8M | — | ||
| Q3 24 | $-27.1M | — | ||
| Q2 24 | $16.9M | — |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | — | ||
| Q3 25 | -7.4% | — | ||
| Q2 25 | -3.9% | — | ||
| Q1 25 | -21.2% | 18.1% | ||
| Q4 24 | -11.2% | — | ||
| Q3 24 | -3.3% | — | ||
| Q2 24 | 2.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | — | ||
| Q3 25 | 16.0% | — | ||
| Q2 25 | 19.3% | — | ||
| Q1 25 | 22.7% | 0.5% | ||
| Q4 24 | 26.3% | — | ||
| Q3 24 | 23.3% | — | ||
| Q2 24 | 19.4% | — |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 3.47× | ||
| Q3 25 | 2.02× | 4.30× | ||
| Q2 25 | 4.43× | 9.11× | ||
| Q1 25 | 1.37× | — | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 2.39× | 195.23× | ||
| Q2 24 | 2.18× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
BILI
| Value-added services (VAS) | $466.4M | 37% |
| Advertising | $435.0M | 34% |
| Mobile games | $220.3M | 17% |
| Other | $80.8M | 6% |
| IP derivatives and others | $68.2M | 5% |
